Phylex Biosciences

is a next-generation vaccine company uniquely located at
the crossroads of information technology and biotechnology.

We are developing the first universal vaccine against the SARS coronavirus. Our vaccine is designed to protect not only against SARS-CoV-2 (COVID-19), the virus responsible of the current pandemic, but also against other highly pathogenic SARS coronaviruses of the future.